Dr Reddys Laboratories (RDY) Net Margin Growth (5y) (2014 - 2023)
Dr Reddys Laboratories (RDY) Net Margin Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 833.00 |
| Mar 31, 2023 | 856.00 |
| Dec 31, 2022 | 673.00 |
| Mar 31, 2021 | -508.00 |
| Sep 30, 2020 | -3,069.00 |
| Jun 30, 2020 | 414.00 |
| Sep 30, 2019 | -2,909.00 |
| Mar 31, 2019 | 158.00 |
| Dec 31, 2018 | -554.00 |
| Sep 30, 2018 | -495.00 |
| Jun 30, 2018 | -739.00 |
| Mar 31, 2018 | 1,251.00 |
| Dec 31, 2017 | -860.00 |
| Sep 30, 2017 | -929.00 |
| Dec 31, 2016 | -460.00 |
| Sep 30, 2016 | 1,453.00 |
| Mar 31, 2016 | 341.00 |
| Dec 31, 2015 | -894.00 |
| Sep 30, 2015 | 4,205.00 |
| Jun 30, 2015 | 282.00 |